DiaCarta工商信息_电话_地址_信用信息_财务信息

公司简介

DiaCarta is a translational genomics and personalized diagnostics company based in Richmond, California. Our mission is to provide highly sensitive and advanced technologies that will improve the way molecular diagnostics and translational genomics impact healthcare treatment plans and the well-being of individuals around the world. With over 18,000 square feet dedicated to a GMP-compliant lab space as well as CLIA and ISO 13485 certifications, DiaCarta is changing the landscape of molecular diagnostics.

主要成员

Aiguo Zhang、Paul Okunieff

产品/服务

XNA Molecular Clamp	Molecular forceps for qPCR.
SuperbDNA	DNA or RNA for the detection of cancer biomarkers, bacteria, fungi and viruses.
DigiPlex™ Genotyping	DigiPlex Genotyping Test.
NGS Targeted Sequencing	To achieve ultra-sensitive detection of gene mutations, eliminating the cost and time constraints.
Next-Gen Sequencing	Sample & Library Preparation,Next Generation Sequencing,Genome Annotation.

QClamp Gene Mutation Detection Kits	A highly sensitive qPCR assay kit with 0.1% detection sensitivity or lower.
Colon Cancer Tests	Used for the qualitative detection of colorectal cancer-associated biomarkers in FFPE tissue samples.
DNA Sample Card	DNA extraction and preservation in saliva, blood (serum, whole blood), urine, feces, amniotic fluid, cervical fluid, tumor cells, plant leaf marks and tissue homogenates.
PCR Ready Lysis Buffers	For isolation of DNA from formalin-fixed paraffin-embedded (FFPE) sample.
Adapter Dimer Removal	XNA clamps are used to block adapter-adapter junctions
CRISPR Gene Editing	Provides fast, low-cost, ultra-sensitive quantification of NHEJ and HDR editing events.
Genotyping Tests	Provides a platform for digital multiplexing of proteins and DNA with bar code beads.

Adapter Dimer Removal

CRISPR Gene Editing

融资信息

融资轮次	融资日期	投资方	融资额度
A轮	2015-01	未披露	$8M

关联公司